{
  "Country": "EN",
  "PICOs": [
    {
      "Population": "People with previously treated KRAS G12C mutation-positive advanced NSCLC",
      "Intervention": "Sotorasib",
      "Comparator": "Docetaxel",
      "Outcomes": "Overall survival and progression-free survival"
    },
    {
      "Population": "People with previously treated KRAS G12C mutation-positive advanced NSCLC",
      "Intervention": "Sotorasib",
      "Comparator": "Docetaxel plus nintedanib",
      "Outcomes": "Overall survival and progression-free survival"
    },
    {
      "Population": "People with advanced NSCLC",
      "Intervention": "Docetaxel plus nintedanib",
      "Comparator": "Docetaxel",
      "Outcomes": "Overall survival and progression-free survival"
    }
  ]
}